Trulicity is the brand name Eli Lilly uses for dulaglutide, a GLP-1 receptor agonist approved by the FDA in September 2014 (BLA 125469) for type 2 diabetes. Trulicity ships in a once-weekly, single-use autoinjector pen and is not FDA-approved for weight loss, unlike Ozempic's sister drug Wegovy or Mounjaro's sister drug Zepbound. Trulicity was one of the earliest weekly GLP-1 agonists on the US market and remains widely prescribed for adults managing type 2 diabetes who need an alternative to daily injections or oral agents.
The wholesale acquisition cost for a Trulicity carton is approximately $987 per month across all dose strengths (0.75 mg through 4.5 mg) in 2026. What a patient actually pays depends heavily on insurance status: commercially insured patients can use the Trulicity Savings Card to pay as little as $25, uninsured or Medicare Part D patients who qualify by income can receive Trulicity free through the Lilly Cares Foundation patient assistance program, and everyone else pays a share tied to their plan's formulary tier. Trulicity falls under the standard 2026 Medicare Part D annual out-of-pocket cap of $2,100 rather than a drug-specific cap like the $35 insulin cap.
CMS selected Trulicity on January 27, 2026 as one of 15 drugs entering the third cycle of Medicare drug price negotiation under the Inflation Reduction Act. This is the first negotiation cycle to include drugs billed under Medicare Part B in addition to Part D drugs. Negotiations between CMS and Eli Lilly run through 2026, and any negotiated Maximum Fair Price becomes effective January 1, 2028, not 2026. Trulicity was not part of the first negotiation round (the 10 drugs with prices effective January 1, 2026, including Eliquis and Jardiance) or the second round (semaglutide products effective 2027). Patients comparing weekly GLP-1 diabetes drugs should also review Ozempic cost and Mounjaro cost for pricing differences.
What Trulicity Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same trulicity can cost many times more at a hospital than at your local pharmacy:
2026 Trulicity Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter (retail, cash, no insurance) | $950 - $1,200/month | List price for a four-pen, 28-day carton, any dose strength, in 2026 |
| Medicare Part D (2026) | Specialty-tier copay, capped at $2,100/year | Prior authorization typically required; type 2 diabetes indication only |
| Commercial insurance (with prior authorization) | $25 - $300/month after PA | Formulary tier and step therapy vary by plan; savings card can lower to $25 |
| Trulicity Savings Card | $25 for up to a 3-month fill; $1,950/year cap | Commercial insurance only; not valid for Medicare, Medicaid, TRICARE, or VA |
| Medicaid | $1 - $4/prescription, with PA | Covered for type 2 diabetes in most states; formulary rules vary by state |
Retail prices reflect 2026 GoodRx and pharmacy survey data. Part D copays depend on your plan's formulary tier and where you are in your benefit year. Medicaid coverage and copay amounts vary by state program.
Source: CMS Part D 2026 benefit design, Eli Lilly Trulicity pricing, Lilly Cares Foundation, GoodRx
Why Hospitals Charge So Much
Trulicity is a self-administered, once-weekly outpatient injection, so it rarely appears as an active treatment on an inpatient hospital bill. When Trulicity does show up on a hospital bill, it is almost always a continuation of a patient's home regimen during an unrelated hospital admission, not a drug administered by hospital staff for an acute condition. In that situation, hospitals apply their standard pharmacy acquisition markup on top of whatever they paid for the pen, and that markup routinely runs several times the retail price.
The more common affordability problem with Trulicity is the gap between the $987 wholesale list price and what a patient actually pays based on insurance status. Pharmacy benefit managers negotiate rebates with Eli Lilly that lower what the health plan pays, but those rebate savings do not automatically flow through to the patient at the pharmacy counter. Patients on high-deductible health plans frequently pay close to the full list price until their deductible resets, which is why the manufacturer coupon and patient assistance program matter more than the sticker price.
For Medicare beneficiaries, the 2026 Part D annual out-of-pocket cap of $2,100 provides real protection against a drug priced above $900 per month. A patient filling Trulicity continuously for a year at list price would spend nearly $12,000. Under Part D, that patient's out-of-pocket exposure stops at $2,100, after which covered drugs cost $0 for the rest of the plan year. Medicare beneficiaries can also ask their Part D plan about the Medicare Prescription Payment Plan, which spreads out-of-pocket costs evenly across the calendar year instead of front-loading them in the first few months.
Patient Assistance Programs
Eli Lilly operates two programs that meaningfully lower Trulicity's out-of-pocket cost: the Trulicity Savings Card for commercially insured patients, and the Lilly Cares Foundation patient assistance program for uninsured or income-qualified Medicare Part D patients. If you have no insurance at all and cannot afford $950 to $1,200 per month, the Lilly Cares Foundation route is the one to pursue first.
Patient assistance programs for Trulicity| Manufacturer program | Cost / Benefit | How to apply |
|---|
| Trulicity Savings Card (commercially insured) | $25 for up to a 3-month fill; maximum savings of $150/month, $300/2-month, or $450/3-month fill; $1,950 annual cap | trulicity.lilly.com/savings-resources |
| Lilly Cares Foundation Patient Assistance Program | Free Trulicity for uninsured patients or Medicare Part D enrollees (without full Extra Help) with income at or below 400% FPL; up to a 12-month supply | lillycares.com |
| NeedyMeds Drug Discount Card | Variable discount accepted at most US pharmacies; no income verification required | needymeds.org |
Manufacturer savings cards like the Trulicity Savings Card are blocked by federal anti-kickback law (42 U.S.C. Section 1320a-7b) from Medicare, Medicaid, TRICARE, and VA beneficiaries. If you have any government-funded insurance, use the Lilly Cares Foundation patient assistance program instead. Unusually, Lilly Cares accepts Medicare Part D enrollees for Trulicity as long as they are not also receiving full Extra Help (Low-Income Subsidy) and meet the income threshold.
Source: Eli Lilly Trulicity savings program pages, Lilly Cares Foundation, NeedyMeds.org
Medicare Part D
Medicare Part D covers Trulicity when prescribed for type 2 diabetes. Most Part D formularies place Trulicity on a specialty tier (Tier 3 or 4), which carries a higher coinsurance percentage than generic or preferred-brand tiers. Plans typically require prior authorization confirming a type 2 diabetes diagnosis (ICD-10 code E11.x) and often documented HbA1c results or prior use of metformin before approving coverage.
In 2026, the Medicare Part D annual out-of-pocket cap is $2,100. That cap applies across all your Part D drugs combined, not just Trulicity, and it replaced the old catastrophic-phase coinsurance under the Inflation Reduction Act. A patient with Trulicity on a specialty tier will typically reach the $2,100 cap within the first two to three months of the plan year, after which covered drugs cost $0 for the remainder of the calendar year.
Medicare beneficiaries cannot use the Trulicity Savings Card, but the Lilly Cares Foundation makes an exception for Trulicity: Medicare Part D enrollees who do not receive full Extra Help and who meet the 400% FPL income threshold can qualify for free Trulicity through the foundation. If your Part D plan denies coverage or your copay is unaffordable, ask your prescriber to help file a formulary exception, and ask your Part D plan about the Medicare Prescription Payment Plan to spread costs across the year.
Common Trulicity Billing Errors
If you received a bill for Trulicity above $300 with commercial insurance, or above the specialty-tier copay expected under Medicare Part D, check for these issues before paying:
- Prior authorization not submitted or denied without appeal: most Part D and commercial plans require PA for Trulicity, including HbA1c results and a type 2 diabetes ICD-10 code. If your prescriber's office did not submit one, you may be paying cash unnecessarily.
- Savings card rejected at the pharmacy for Medicare or Medicaid patients: the Trulicity Savings Card is not valid for anyone enrolled in a federally funded health program. Medicare patients should instead apply for the Lilly Cares Foundation PAP.
- Wrong GLP-1 product billed: Trulicity, Ozempic, and Mounjaro have different NDC codes and different coverage rules even though they are all weekly injectable diabetes drugs. Confirm the dispensed product on the pharmacy label matches the prescription exactly.
- Four-pen carton billed as multiple separate fills, multiplying your copay. One carton contains a four-week supply; a single carton fill should equal one copay, not four.
- Charged the standard cost-sharing rate after you already reached the $2,100 Part D out-of-pocket cap for the calendar year.
- Inpatient hospital charge for a partial Trulicity pen marked up to several thousand dollars when the retail equivalent is under $1,200 for a full month's carton.
Frequently Asked Questions
Is there a generic or biosimilar version of Trulicity?
No. As of 2026, no FDA-approved generic or biosimilar dulaglutide exists. Trulicity is a biologic approved under a Biologics License Application, so any follow-on version requires FDA biosimilar approval rather than a standard generic filing. Trulicity's reference-product exclusivity expires in September 2026, but analysts do not expect a biosimilar dulaglutide to reach US pharmacies before 2028 at the earliest. The Trulicity Savings Card and Lilly Cares Foundation PAP are the current cost-reduction options.
How do I apply for the Lilly Cares Foundation patient assistance program for Trulicity?
Call 1-800-545-6962 or visit lillycares.com to start an application. You will need proof of household income (tax return or four pay stubs), proof of US residency, a current Trulicity prescription, and documentation showing you are either uninsured or a Medicare Part D enrollee without full Extra Help. Your household income must fall at or below 400% of the federal poverty level. Processing takes about 2 to 3 weeks, and approved patients receive up to a 12-month supply free of charge.
Can I use the Trulicity savings card with Medicare?
No. Federal anti-kickback law bars manufacturer copay savings cards, including the Trulicity Savings Card, from anyone enrolled in Medicare, Medicaid, TRICARE, or VA benefits. The savings card is for commercially insured patients only and caps the cost at $25 for up to a 3-month fill. If you have Medicare Part D and do not receive full Extra Help, apply to the Lilly Cares Foundation instead, which does accept Medicare Part D enrollees for Trulicity.
What if my insurance denies coverage for Trulicity?
Request a written denial notice, then file a formal appeal within 60 days with a prescriber letter documenting medical necessity and prior treatment history. If the appeal is denied, ask your prescriber to request a peer-to-peer review, and escalate to external review through your state Department of Insurance or Medicare's Independent Review Entity if needed. While you appeal, the Lilly Cares Foundation can supply Trulicity at no cost if you meet the income and insurance requirements.
Does the IRA negotiated Medicare price apply to Trulicity in 2026?
Not yet. Trulicity was not part of the first Medicare drug price negotiation round (10 drugs effective January 1, 2026, including Eliquis and Jardiance) or the second round (semaglutide products effective 2027). CMS selected Trulicity on January 27, 2026 for the third negotiation cycle, and any negotiated Maximum Fair Price will not take effect until January 1, 2028. Through 2026 and 2027, Trulicity's Medicare Part D coverage follows standard formulary rules and the annual $2,100 out-of-pocket cap.
What does Trulicity cost without insurance at the pharmacy counter in 2026?
Cash retail prices for a four-pen, 28-day Trulicity carton run $950 to $1,200 per month depending on the pharmacy in 2026. Costco Pharmacy typically has the lowest cash price around $940 to $980, while Walgreens tends to run highest at $1,050 to $1,200. A GoodRx coupon at CVS brings the price to roughly $980 to $1,040. Uninsured patients earning at or below 400% of the federal poverty level should apply to the Lilly Cares Foundation for free Trulicity instead of paying cash.
Do I qualify for the Lilly Cares Foundation patient assistance program?
You likely qualify if you are a US resident, have a valid Trulicity prescription, and either have no prescription drug insurance or have Medicare Part D without full Extra Help (Low-Income Subsidy), and your household income is at or below 400% of the federal poverty level in 2026 (for example, $63,840 for one person or $132,000 for a family of four). You do not qualify if you are enrolled in Medicaid, have commercial insurance covering Trulicity, or exceed the income threshold.
How is Trulicity different from Ozempic and Mounjaro?
All three are once-weekly injectable diabetes drugs but use different molecules. Trulicity (dulaglutide) is a GLP-1 receptor agonist approved only for type 2 diabetes, with no FDA-approved weight-loss version. Ozempic (semaglutide) is also a GLP-1 agonist and has a weight-loss sibling drug, Wegovy. Mounjaro (tirzepatide) is a dual GIP/GLP-1 agonist with a weight-loss sibling drug, Zepbound. Pricing, savings card terms, and Medicare IRA negotiation timelines differ across all three.
